在研机构 |
权益机构- |
最高研发阶段批准上市 |
首次获批日期 美国 (1958-01-20), |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C8H7N3O5 |
InChIKeyPLHJDBGFXBMTGZ-UHFFFAOYSA-N |
CAS号67-45-8 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
霍乱 | 中国 | 1981-01-01 | |
痢疾 | 中国 | 1981-01-01 | |
贾第虫病 | 中国 | 1981-01-01 | |
滴虫感染 | 中国 | 1981-01-01 | |
伤寒 | 中国 | 1981-01-01 | |
肠炎 | 美国 | 1958-01-20 |
N/A | - | - | Clarithromycin-based bismuth-containing quadruple therapy (C-BQT) | 鑰憲網觸衊簾壓簾醖淵(構餘築簾遞範壓鹽壓壓) = Frequencies of adverse events in F-BQT and C-BQT had no differences (36.0% in C-BQT vs 32.6% in F-BQT, P = 0.499) 願夢餘積窪遞鬱築鹹艱 (簾積觸艱構鹹製築襯廠 ) | 积极 | 2021-09-01 | |
N/A | - | - | Furazolidone-amoxicillin quadruple therapy | 鹽鏇醖遞鑰鏇簾餘鹽遞(壓鑰鏇艱夢鏇襯製壓艱) = 積憲衊衊網淵蓋範繭築 鬱構夢鏇範鏇鬱醖鑰艱 (膚繭淵積獵襯鬱窪餘網, 94–96) | - | 2018-10-01 | |
N/A | - | - | OABF | 鹽獵網構鏇簾鏇觸餘顧(窪鬱鹹繭繭憲鹹選獵網) = more frequently in group C (OAF) with p<0.05 獵獵鑰繭艱遞製蓋範衊 (構範糧獵餘遞網觸淵艱 ) | - | 2013-10-01 | |
OABM-F | |||||||
N/A | 幽门螺杆菌感染 二线 | 176 | Triple therapy | 範選遞簾築鹽製襯觸餘(鬱鬱網窪鏇獵淵顧夢顧) = 鹽壓廠夢廠廠獵鬱糧齋 壓鹽餘襯顧鑰遞壓鹽襯 (鹹糧網齋築築獵簾製廠 ) | - | 2009-09-01 | |
Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole | 範選遞簾築鹽製襯觸餘(鬱鬱網窪鏇獵淵顧夢顧) = 憲網選襯觸鑰繭襯壓壓 壓鹽餘襯顧鑰遞壓鹽襯 (鹹糧網齋築築獵簾製廠 ) |